Brassica’s Truebroc brand glucoraphanin received a “no objection” letter from FDA for its GRAS notification.
Photo © iStockphoto.com/MarenWischnewski
Truebroc brand glucoraphanin is now the first broccoli-source glucoraphanin to obtain Generally Recognized As Safe (GRAS) status from FDA. Supplier Brassica Protection Products (Baltimore, MD) recently announced it has received a “no objection” letter from FDA regarding Truebroc’s GRAS notification.
A phytonutrient, glucoraphanin is a dietary precursor of the antioxidant sulforaphane. Researchers have found sulforaphane to be a potent inducer of cytoprotective phase 2 enzyme that help eliminate free radicals in the body, according to Brassica. A recent study also found that sulforaphane may be equally bioavailable if obtained from broccoli sprouts or glucoraphanin supplements sourced from broccoli seeds, such as Truebroc.
In 2013, an independent panel concluded Truebroc was GRAS for use in food applications after reviewing the public literature on glucoraphanin sourced from broccoli seeds. With guidance from Spherix Consulting (Irvine, CA), Brassica submitted its GRAS notification to FDA in December 2013. A little more than two years later, on January 19, 2016, the company announced FDA had replied with a “no objection” letter.
“The successful review of our GRAS dossier for Truebroc reaffirms all of the time, extensive research, and testing we dedicate to demonstrating the product’s safety,” said Tony Talalay, CEO of Brassica. He also highlighted the fact that Truebroc’s GRAS dossier included a complete safety review of its water-extraction production process.
“We look forward to promoting the health benefits and safety profile of Truebroc to food, beverage, and supplement manufacturers who want to add glucoraphanin to their consumer products,” Talalay said.
Read more:
Sulforaphane Shows Similar Bioavailability from Glucoraphanin Supplements as from Broccoli Sprouts?
Broccoli-Antioxidant Action Lasts Longer than Vitamin C, Polyphenols, Glanbia Explains
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.